Basso U - Search Results

1

Safety and Efficacy of Tivozanib in First-Line mRCC: A Multicenter Compassionate-Use Study (Meet-Uro 16).

Basso U, Procopio G, Fornarini G, Massari F, Bearz A, Fratino L, Milella M, Bassanelli M, Ermacora P, Bimbatti D, Verzoni E, Rizzo M, Porta C. Basso U, et al. Oncology. 2021;99(12):747-755. doi: 10.1159/000515951. Epub 2021 Sep 28. Oncology. 2021. PMID: 34583356

2

Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study.

Brandes AA, Ermani M, Basso U, Amistà P, Berti F, Scienza R, Rotilio A, Pinna G, Gardiman M, Monfardini S. Brandes AA, et al. Among authors: basso u. Ann Oncol. 2001 Feb;12(2):255-7. doi: 10.1023/a:1008336732273. Ann Oncol. 2001. PMID: 11300334 Free article. Clinical Trial.

3

Temozolomide in patients with glioblastoma at second relapse after first line nitrosourea-procarbazine failure: a phase II study.

Brandes AA, Ermani M, Basso U, Paris MK, Lumachi F, Berti F, Amistà P, Gardiman M, Iuzzolino P, Turazzi S, Monfardini S. Brandes AA, et al. Among authors: basso u. Oncology. 2002;63(1):38-41. doi: 10.1159/000065718. Oncology. 2002. PMID: 12187069 Clinical Trial.

4

Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase II study.

Brandes AA, Basso U, Vastola F, Tosoni A, Pasetto LM, Jirillo A, Lonardi S, Paris MK, Koussis H, Monfardini S, Ermani M. Brandes AA, et al. Among authors: basso u. Ann Oncol. 2003 Dec;14(12):1727-31. doi: 10.1093/annonc/mdg494. Ann Oncol. 2003. PMID: 14630676 Free article. Clinical Trial.

5

Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

Brandes AA, Tosoni A, Basso U, Reni M, Valduga F, Monfardini S, Amistà P, Nicolardi L, Sotti G, Ermani M. Brandes AA, et al. Among authors: basso u. J Clin Oncol. 2004 Dec 1;22(23):4779-86. doi: 10.1200/JCO.2004.06.181. J Clin Oncol. 2004. PMID: 15570079 Clinical Trial.

6

Which benefit from adding gemcitabine to vinorelbine in elderly (>or=70 years) women with metastatic breast cancer? Early interruption of a phase II study.

Basso U, Fratino L, Brunello A, Lumachi F, De Salvo GL, Lonardi S, Ghiotto C, Koussis H, Pasetto LM, Monfardini S. Basso U, et al. Ann Oncol. 2007 Jan;18(1):58-63. doi: 10.1093/annonc/mdl338. Epub 2006 Oct 6. Ann Oncol. 2007. PMID: 17028243 Free article. Clinical Trial.

7

Management of Frail and Not-Frail elderly cancer patients in a hospital-based geriatric oncology program.

Basso U, Tonti S, Bassi C, Brunello A, Pasetto LM, Scaglione D, Falci C, Beda M, Aversa SM, Stefani M, Castegnaro E, Tamellini F, Monfardini S. Basso U, et al. Crit Rev Oncol Hematol. 2008 May;66(2):163-70. doi: 10.1016/j.critrevonc.2007.12.006. Epub 2008 Feb 19. Crit Rev Oncol Hematol. 2008. PMID: 18243726

8

Genotype-driven phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer.

Toffoli G, Cecchin E, Gasparini G, D'Andrea M, Azzarello G, Basso U, Mini E, Pessa S, De Mattia E, Lo Re G, Buonadonna A, Nobili S, De Paoli P, Innocenti F. Toffoli G, et al. Among authors: basso u. J Clin Oncol. 2010 Feb 10;28(5):866-71. doi: 10.1200/JCO.2009.23.6125. Epub 2009 Dec 28. J Clin Oncol. 2010. PMID: 20038727 Free PMC article. Clinical Trial.

9

Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy.

International Prognostic Factors Study Group; Lorch A, Beyer J, Bascoul-Mollevi C, Kramar A, Einhorn LH, Necchi A, Massard C, De Giorgi U, Fléchon A, Margolin KA, Lotz JP, Germa Lluch JR, Powles T, Kollmannsberger CK. International Prognostic Factors Study Group, et al. J Clin Oncol. 2010 Nov 20;28(33):4906-11. doi: 10.1200/JCO.2009.26.8128. Epub 2010 Oct 18. J Clin Oncol. 2010. PMID: 20956623

10

Safety and activity of sunitinib in elderly patients (≥ 70 years) with metastatic renal cell carcinoma: a multicenter study.

Brunello A, Basso U, Sacco C, Sava T, De Vivo R, Camerini A, Barile C, Roma A, Maruzzo M, Falci C, Zagonel V. Brunello A, et al. Among authors: basso u. Ann Oncol. 2013 Feb;24(2):336-342. doi: 10.1093/annonc/mds431. Epub 2012 Oct 9. Ann Oncol. 2013. PMID: 23051952 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

258 results

Search Page